ARCT FY 2018 Earnings — Arcturus Therapeutics Holdings Inc. Revenue & Financial Results | Market Cap Arena

ARCTArcturus Therapeutics Holdings Inc.

$210M

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$16M+21.2% YoY

Gross Profit

-$1M-7.8% margin

Operating Income

-$22M-138.5% margin

Net Income

-$22M-138.3% margin

EPS (Diluted)

$-2.16

Cash Flow

Operating Cash Flow

-$21M

Free Cash Flow

-$22M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$44M

Total Liabilities

$31M

Stockholders' Equity

$14M

Cash & Equivalents

$37M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$16M	$13M	+21.2%
Gross Profit	-$1M	$13M	-109.8%
Operating Income	-$22M	-$10M	-107.9%
Net Income	-$22M	-$11M	-99.8%